Showing results (251-260 of 298) with videos related to

Sort By:
Pageof 30
British Journal of Haematology|September 21, 2025
The epidemiological landscape of bloodstream infections in children undergoing chemotherapy or haematopoietic cell transplantation: A retrospective study by Infectious Diseases Working Group of Italian Association of Pediatric Hematology and Oncology (AIEOP)Francesco Baccelli, Francesca Compagno, Gloria Tridello, et al.
Bone Marrow Transplantation|May 13, 2026
Central nervous system complications after allogeneic haematopoietic cell transplantation: best practice recommendations from the EBMT practice harmonisation and guidelines committee on epidemiology, outcome and neuroimagingMartin Schmidt-Hieber, Roser Velasco, Olaf Penack, et al.
Blood Cells, Molecules & Diseases|May 16, 2015
Diagnosis and management of acquired aplastic anemia in childhood. Guidelines from the Marrow Failure Study Group of the Pediatric Haemato-Oncology Italian Association (AIEOP)Angelica Barone, Annunziata Lucarelli, Daniela Onofrillo, et al.
Hemasphere|November 3, 2025
Isatuximab in combination with chemotherapy for pediatric patients with relapsed/refractory acute lymphoblastic leukemia or acute myeloid leukemia: The ISAKIDS studyAndré Baruchel, Karsten Nysom, Hyoung Jin Kang, et al.
Annals of Hematology|June 21, 2022
Favorable outcome of SARS-CoV-2 infection in pediatric hematology oncology patients during the second and third pandemic waves in Italy: a multicenter analysis from the Infectious Diseases Working Group of the Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP)Daniele Zama, Francesco Baccelli, Antonella Colombini, et al.
Bone Marrow Transplantation|January 30, 2021
Impact of early candidemia on the long-term outcome of allogeneic hematopoietic stem cell transplant in non-leukemic patients: an outcome analysis on behalf of IDWP-EBMTSimone Cesaro, Gloria Tridello, Nina Simone Knelange, et al.
Bone Marrow Transplantation|May 7, 2026
Symptom-guided approach to central nervous system complications in allogeneic hematopoietic cell transplant recipients: Best practice recommendations from the EBMT Practice Harmonisation and Guidelines committeeRoser Velasco, Martin Schmidt-Hieber, Olaf Penack, et al.
Bone Marrow Transplantation|May 6, 2023
Decrease of lethal infectious complications in the context of causes of death (COD) after hematopoietic cell transplantation: COD-2 and COD-1 study of the Infectious Diseases Working Party EBMTJan Styczynski, Gloria Tridello, Linda Koster, et al.
British Journal of Haematology|April 29, 2025
Underlying disease is the main risk factor in post-splenectomy complication risk: Data from a national databaseMaddalena Casale, Raffaella Colombatti, Manuela Balocco, et al.
Bone Marrow Transplantation|August 1, 2019
Prognostic impact of EBV serostatus in patients with lymphomas or chronic malignancies undergoing allogeneic HCTJan Styczynski, Gloria Tridello, Lidia Gil, et al.
Pageof 30